Oral Oncology

Papers
(The TQCC of Oral Oncology is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Rare mandibular metastasis of Ewing sarcoma presenting as an endodontic infection82
Comment on “Circulating miRNAs as diagnostic biomarkers in HPV-associated oropharyngeal squamous cell carcinoma (OPSCC)”75
Commentary on, “Optimization of methylation capture sequencing workflow in formalin fixed tissue from oral squamous cell carcinoma patients”55
Commentary on, “Transoral endoscopic thyroidectomy vestibular approach for pT1b papillary thyroid carcinoma: Surgical and oncological outcomes.”45
Comment on “Extensive necrosis of the tongue as a very early adverse event of head and neck radiotherapy”43
Authors reply to the comment on: Association of sarcopenia with oncologic outcomes of primary treatment among patients with oral cavity cancer: A systematic review and meta-analysis41
Inter-assay reliability of programmed cell death-ligand 1 in head and neck squamous cell carcinoma39
Comments on the article titled “Factors associated with unknown primary status in head and neck squamous cell carcinoma”: Is the N status the overlooked elephant in the room?39
Illustrating potential actionable drug targets of head and neck tumors based on comprehensive genomic landscape of 386 samples38
DNA Methylation Mediated Epigenetic Silencing of PD-1 and PD-L1: Therapeutic Implications in Oral Cancer36
Is 55 years an optimal age cutoff point for clinical staging in T1 papillary thyroid cancer?36
“Haemophilia A” – Presenting with oral squamous cell carcinoma diagnosis and management strategies35
P28 Head and neck cancer cells differentiate resembling their tissue of origin34
Radiation-induced osteosarcoma in the head and neck region: Case report and literature review33
Restoring the anti-tumor property of PTEN: A promising oral cancer treatment33
Comment on: “Feasibility and preliminary efficacy of a lymphedema and fibrosis self-management program for head and neck cancer survivors: A pilot randomized controlled trial”32
Division versus de-epithelialization of fibula osteocutaneous flap for composite oromandibular defects: A propensity score-matched analysis32
Letter to editor on “Proton therapy re-irradiation outcomes and genomic landscape of patients with recurrent head and neck cancer”31
Letter to the editor, “Letter to the editor, “Short-term versus long-term metronomic adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma: A propensity score-matched real-world study.”31
Effective, efficient palliative radiotherapy for advanced head and neck cancer: Real world data using 25 Gy in 5 fractions31
What does margin mean in laryngeal surgery?30
Comment on: Predictors of recurrence, and the impact of adjuvant radiation therapy on survival in early stage (pT1–2, N0) oral cavity squamous cell carcinoma: A matched pair analysis29
Corrigendum to salivary microRNA- 375: A novel biomarker in the malignant transformation of oral potentially malignant disorders [Oral Oncol. 134 (2022) 106065]29
Evaluation of the matrix metalloproteinase 9 (MMP9) inhibitor Andecaliximab as an Anti-invasive therapeutic in Head and neck squamous cell carcinoma29
Oncological outcomes of compartmental surgery and wide local excision in oral tongue and floor of the mouth cancer28
Correction to “My letter: Do we recognize oral oncology with accuracy? AI-driven models serve in the diagnosis of oral squamous cell carcinoma”28
Health-related quality of life after free flap reconstruction of maxillary defects: a systematic review and meta-analysis28
Evaluation of Otolaryngology Provider Bias in Portal Messaging28
Head and neck cancer with synchronous nodules of the lung as a diagnostic and therapeutic challenge – A systematic review27
Adjuvant radiotherapy mitigates impact of perineural invasion on oncologic outcomes in early-stage oral cavity squamous cell carcinoma. A multi-institutional analysis of 557 patients27
Characterization of oral microbiota in HPV and non-HPV head and neck squamous cell carcinoma and its association with patient outcomes26
A single-cell sequencing-based analysis of a 13-year-old with maxillary sinus NUT carcinoma26
Tumor subtype classification tool for HPV-associated head and neck cancers26
Machine learning driven index of tumor multinucleation correlates with survival and suppressed anti-tumor immunity in head and neck squamous cell carcinoma patients26
Myxoid variant of extramammary myofibroblastoma affecting the buccal mucosa: An extremely rare oral lesion and literature review26
Sentinel lymph node biopsy in recurrent or secondary oral squamous cell carcinoma after previous neck dissection25
Corrigendum to “Epigenetics: Promising journey so far but ways to go in head neck cancer” [Oral Oncol. 135 (2022) 106194]25
Required time for pre-oncological dental management – A rapid review of the literature25
Overestimated risk of transformation in oral lichen planus25
The prognostic role of tumor associated macrophages in squamous cell carcinoma of the head and neck: A systematic review and meta-analysis24
Artificial intelligence for oral cancer diagnosis: What are the possibilities?24
Combination kinase inhibitors and immunotherapy for unresectable anaplastic thyroid carcinoma: A retrospective single-center study24
Burden of oral cancer and associated risk factors at national and state levels: A systematic analysis from the global burden of disease in India, 1990–202123
Clinical outcomes of oropharyngeal squamous cell carcinoma stratified by human papillomavirus subtype: A systematic review and meta-analysis23
Turning tumor microenvironmental foes to friends: A new opportunity for thyroid cancer therapy and redifferentiation23
The effect of skeletal muscle mass on dose-limiting toxicities during (chemo)radiotherapy in patients with head and neck cancer: A systematic review and meta-analysis23
Muscle quality and not quantity as a predictor of survival in head and neck squamous cell carcinoma23
Prognostic effect of surgical treatment in elderly oral squamous cell carcinoma patients: A retrospective study23
“Time is not to be wasted”23
Radiation-induced sarcomas of the craniofacial region: A systematic review23
Risks of central lymph node metastasis in papillary thyroid carcinoma with or without multifocality in at least one lobe: A multi-center analysis22
Management of head and neck cancer around the world: an international survey by the world ear, nose, and throat federation22
Commentary on, “Margin analysis of radical tonsillectomy specimens following transoral robotic surgery”22
ChatGPT: Empowering dentistry with future possibilities22
Intrathyroid thymic carcinoma diagnosed following an odontogenic infection: Insights from a rare clinical presentation22
Comment on “The circadian clock gene, BMAL1, promotes radiosensitization in nasopharyngeal carcinoma by inhibiting the epithelial-to-mesenchymal transition via the TGF-β1/Smads/Snail1 axis”21
Completion thyroidectomy for intermediate risk factors after thyroid lobectomy21
Papillary thyroid cancer in black thyroid: A case report21
Evaluating the prognostic value of tumor-derived circulating endothelial cells and their progenitors in platinum-refractory oral cancer patients for response to triple metronomic therapy21
Letter to the Editor: Prognostic value of age-adjusted comorbidity scoring in OSCC - a step toward personalized oncology21
Commentary on: From mutation maps to clinical impact: Unraveling OSCC genomics in a japanese nationwide cohort21
Potential use of salivary mRNA-based biomarkers to predict oral squamous cell carcinoma21
Comment on “The association between health-related quality of life and five-year overall survival among head and neck cancer patients: A prospective cohort study”21
Comment on: Planned dose of intensity modulated proton beam therapy versus volumetric modulated arch therapy to tooth-bearing regions20
P29 Comparison of selected clinical factors and treatment results according to HPV status in patients with oropharyngeal cancer treated with radiotherapy alone or combined with chemotherapy20
O1.3 Awareness of HPV-associated oropharyngeal cancer among the general population and general practitioners in the Netherlands: Cross-sectional study20
FLASH radiotherapy in head and neck cancer: Myth or reality?20
Editorial Board20
P25 The role of ultrasound elastography for clinical neck staging in HPV-related oropharyngeal cancer20
Comment on letters to the editor in oral oncology referring to microRNAs as therapeutic molecules for oral squamous cell carcinoma19
Letter to the Editor: Whole-exome sequencing reveals the mutational landscape of head and neck lymphoepithelioma-like carcinoma19
Editorial Board/Aims & Scope19
Can miR-21 be considered as a potential biomarker and a therapeutic target in oral cancer?19
Prospective study of algorithm-based chemoradioselection to optimize treatment intensity for advanced head and neck cancer19
P35 Spatial proteomics and metabolomics investigations in head & neck cancers19
Mildly dysplastic oral lesions with optically-detectable abnormalities share genetic similarities with severely dysplastic lesions19
Is postoperative adjuvant therapy necessary for pT3N0 oral cavity squamous cell carcinoma?18
Corrigendum to “Analysis of AI foundation model features decodes the histopathologic landscape of HPV-positive head and neck squamous cell carcinomas”. [Oral Oncol. 163 (2025) 107207]18
Whole-exome sequencing reveals the mutational landscape of head and neck lymphoepithelioma-like carcinoma18
Salvage surgery in nasopharyngeal Cancer: Unraveling the efficacy of transnasal endoscopic nasopharyngectomy for advanced stage recurrent tumors18
Clinical outcomes following observation, post-operative radiation therapy, or post-operative chemoradiation for HPV-associated oropharyngeal squamous cell carcinomas18
Comment on “Sex-based immune differences influence tumor progression in head and neck squamous cell carcinoma”18
Refining prognosis and Personalizing Therapy: A Step Forward with Machine learning in HPV-Associated head and neck cancer18
Response to the comment on “The role of the depth of invasion (DOI) in minor salivary glands tumors according to the 8th TNM classification: Pitfalls and potential misinterpretations”17
Discontinuation and nonpublication of nasopharyngeal carcinoma clinical trials17
Elective neck dissection: Are we bound to outdated concepts?17
Comparison between adult comorbidity evaluation-27 and Charlson Comorbidity Index in head and neck oncology17
Corrigendum to “Prognostic factors in surgically treated malignant salivary gland tumors” [Oral Oncol. 144 (2023) 106484]17
Re-evaluating Lymph Node Yield, Lymph Node Ratio, and the number of metastatic nodes as prognostic factors in oral cavity squamous cell carcinoma17
Carcinoma of the parotid Gland: A Population-Based study of incidence and treatment outcomes in 1018 patients17
Long read sequencing identifies complex structural variant landscape and recurrent TERT rearrangements in mucoepidermoid carcinoma17
Beyond binary ENE in HPV-related oropharyngeal cancer: Toward standardized reporting and risk stratification17
De-escalation in high-risk HPV-positive OPC: critical appraisal of methodology and inference17
Dynamic changes of the EMT spectrum between circulating tumor cells and the tumor microenvironment in human papillomavirus-positive head and neck squamous cell carcinoma16
BRAFV600E mutation does not predict lymph node metastases and recurrence in Chinese papillary thyroid microcarcinoma patients16
The integration of female physiological and social role factors in HRQOL research16
Critical appraisal of post-treatment monitoring of surgically treated oropharyngeal squamous cell carcinoma patients using human papillomavirus cell-free DNA: promising potential amid methodological c16
Osteoblastoma of the maxilla: A case report and review of the literature16
Letter to Editor on, “De-escalated surgery following neoadjuvant chemoimmunotherapy for locally advanced oral squamous cell carcinoma: A retrospective cohort study”16
Neoadjuvant tislelizumab plus chemotherapy in locally advanced oral and oropharyngeal squamous cell carcinoma: A single-arm phase II clinical trial16
Comment on: Life following total laryngectomy: mixed-model analyses of longitudinal patient-reported outcomes in a prospective cohort16
Palliative care utilization among head and neck cancer patients: A population-based analysis16
Effect of enhanced recovery after radiotherapy (ERAR) on the quality of life in patients with nasopharyngeal carcinoma after radiotherapy: A randomized controlled trial16
The importance of early treatment of oral squamous cell carcinoma: Case report16
Deep learning for the automatic detection and segmentation of parotid gland tumors on MRI16
Comment on, “Characterization of oral microbiota in HPV and non-HPV head and neck squamous cell carcinoma and its association with patient outcomes”15
Precision medicine in Salivary Gland Carcinoma: Insights from breast and prostate cancer15
The case against lingual mucosectomy15
Photobiomodulation for the prevention of oral side effects secondary to head and neck cancer therapy: results of a randomised, single-blind clinical trial15
Correspondence on “Global burdens of nasopharyngeal carcinoma in children and young adults: Trends and predictions to 2040”15
Exploring the potential of gemcitabine, capecitabine, and tislelizumab after anti-PD-1 treatment in nasopharyngeal carcinoma15
Letter to the editor: The efficacy and safety of VEGF/VEGFR inhibitors in patients with recurrent or metastatic nasopharyngeal carcinoma15
Human papillomavirus status and prognosis of oropharyngeal high-grade neuroendocrine carcinoma15
A rare case of extranodal Rosai Dorfman disease of zygoma14
Carotid space involvement is a prognostic factor and marker for induction chemotherapy in patients with nasopharyngeal carcinoma14
Ferroptosis: An emerging therapeutic target for oral cancer14
Mitigating survival disparities in head and neck cancer: urgent need to reduce ED-based biopsy delays14
O3.3 Proximity ligation-based sequencing for mapping viral integration sites in human papillomavirus positive head and neck squamous cell carcinomas14
Metformin and oral cancer14
Letter to the editor, “Immune infiltration at the primary tumor is associated with clinical outcome of patients with extranodal extension of lymph node metastasis in oral cancer”14
Unfamiliar case of metastatic myxoid leiomyosarcoma of mandible14
Comment on “Surgical, functional, and oncological outcomes of transoral robotic surgery for cT1-T3 supraglottic laryngeal cancers: A systematic review”14
Clinical outcomes of patients with pT4a and pT4b oral cavity squamous cell carcinoma – “Need for incorporation of sub classification of pT4b lesions”14
Editorial Board14
Revolutionizing HPV-driven cancer surveillance: A commentary on the validation of the HPV-SEQ liquid biopsy platform14
Management of metastatic head and neck Cancer: An all-in, kitchen-sink Approach?14
Randomized phase 3 noninferiority trial of radiotherapy and cisplatin vs radiotherapy and cetuximab after docetaxel-cisplatin-fluorouracil induction chemotherapy in patients with locally advanced unre13
Late oral adverse effects of chemotherapy for hematological malignancies in children: A systematic review and meta-analysis of case-control studies13
Chemoradiation therapy alters the PD-L1 score in locoregional recurrent squamous cell carcinomas of the head and neck13
CD271high cancer stem cells regulate macrophage polarization in head and neck squamous cell carcinoma13
Hpv-driven rewiring of the tumor immune microenvironment through single-cell profiling informs prognosis and therapy in HNSCC13
Commentary on “Predictive value of CXCL1+_FAP+ phenotype in CAFs for distant metastasis and its correlation with PD-L1 expression in locoregionally advanced nasopharyngeal carcinoma patients”13
FOXP3 inhibits proliferation and migration by competitively inhibiting YAP1 in nasopharyngeal carcinoma13
Curative approaches for adenoid cystic carcinoma: a multifaceted disease13
Superficial angiomyxoma affecting the buccal mucosa: A detailed immunohistochemical study and literature review13
Risk factors and a risk assessment model for venous thromboembolism in head and neck cancer surgery13
Predictive significance of body composition indices in patients with head and neck squamous cell carcinoma treated with nivolumab: A multicenter retrospective study13
Clonal evolution of long-term expanding head and neck cancer organoid: Impact on treatment response for personalized therapeutic screening13
Weekly paclitaxel, carboplatin and cetuximab (PCE) combination followed by nivolumab for recurrent and/or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN)13
Basal cell adenocarcinoma of the soft palate: A closer look for an exceedingly rare salivary gland tumor13
Editorial Board13
CO2-TOLMS for laryngeal cancer in the elderly, pushing the boundaries of partial laryngectomy13
Delta magnetic resonance imaging radiomics features‑based nomogram predicts long‑term efficacy after induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma13
Could definitive radiotherapy be a treatment option for lymphoepithelial carcinoma of major salivary gland: Comparison of clinical outcomes of upfront surgery and upfront chemoradiotherapy13
Impact of HIV status on overall survival in head and neck cancers by anatomical site and stage: A multi-center cohort study13
Editorial Board12
Thyroid volumes after intensity‐modulated radiotherapy as predictors of radiation‐induced hypothyroidism in nasopharyngeal carcinoma: A retrospective study12
Toward comprehensive optimization of larynx-preserving strategies in MI-LSCC12
Merkel cell carcinoma – Time to consider personalized medicine and combinatorial therapeutic strategies12
O3.2 Loss of LRP1B expression drives chemo and radiation resistance in HPV-positive head and neck cancer12
E3 ubiquitin ligases: A therapeutic drug target in head and neck squamous cell carcinoma12
Pain management following transoral robotic surgery for oropharyngeal squamous cell Carcinoma: A systematic review12
Sensitivity of post-treatment surveillance in detecting recurrence and metastasis in surgically treated HPV-positive oropharyngeal squamous cell carcinoma patients12
Corrigendum to “Diagnostic accuracy of FNA to determine HPV status in HPV-associated oropharyngeal squamous cell carcinoma” [Oral Oncol. 134 (2022) 106131]12
Perioral reconstruction by submental flap12
O1.2 Single cell RNA sequencing allows mapping of HPV transcripts in head and neck cancer epithelial cells12
Anti-LGALS3BP antibody-drug conjugate treatment induces durable and potent antitumor response in a preclinical model of adenoid cystic carcinoma12
Mandibular swing approach: 25 years of experience at Istituto Nazionale Tumori of Milan12
Comment on: Development and clinical implementation of a digital workflow utilizing 3D-printed oral stents for patients with head and neck cancer receiving radiotherapy12
Letter to the Editor: “Exploring long-term responses to immune checkpoint inhibitors in recurrent and metastatic head and neck squamous cell Carcinoma”12
Letter to the editor “The use of 3D computer-aided design to optimize photoimmunotherapy catheter placement”12
Comment on: “The role of adjuvant radiotherapy in relation to tumor size for bone-invasive pT4aN0 oral squamous cell carcinoma-A retrospective observational matched cohort study”12
Long-term outcomes of neo-adjuvant chemotherapy on borderline resectable oral cavity cancers: Real-world data of 3266 patients and implications for clinical practice12
EpCAM and EGFR crosstalk in the development of resistance towards Cetuximab treatment in head and neck cancer12
Corrigendum to “Review of STAT3 (Signal Transducers and Activators of Transcription) in head and neck cancer” [Oral Oncol. 51 (2015) 565–569]11
Scapula or Fibula?: Prospective data-driven decision criteria for flap selection in mandibular reconstruction planning11
Feasibility study of intensive intervention using novel trismus device during adjuvant radiation for head and neck cancer: RestorabiteTM11
Extensive necrosis of the tongue as a very early adverse event of head and neck radiotherapy11
Establishing subdivisions of M1 stage nasopharyngeal carcinoma based on decision tree classification: A multicenter retrospective study11
The utility of ultrasonographic surveillance in management of a presumed branchial cleft cyst later confirmed HPV-associated oropharyngeal cancer11
Health-related quality-of-life assessment in patients with oropharyngeal cancer: A comparison of EQ-5D-5L and EORTC instruments11
Are we ready to use ultrasounds in the clinical assessment of depth of invasion and tumor thickness in oral squamous cell carcinoma? Results from a systematic review, meta-analysis and trial sequentia11
Corrigendum to “Flash radiotherapy-gateway to promised land or another mirage” [Oral Oncol. 139 (2023) 106342]11
Bispecific antibodies targeting tumor-associated metalloprotease and recruit NK cells – Multifunctional therapeutic approach against oral cancer11
Editorial Board/Aims & Scope11
Indications for elective neck dissection in cT1N0M0 oral cavity cancer according to the AJCC eight edition: A nationwide study11
Anti-epidermal growth factor receptor targeted therapy-associated ulcerations11
Comment on: Salivary DNA methylation derived estimates of biological aging, cellular frequency, and protein expression as predictors of oral mucositis severity and survival in head and neck cancer pat11
When histology tells a different story: salivary duct carcinoma in disguise11
Incidence and predictive factors for positive non-sentinel lymph nodes in completion neck dissection following a positive sentinel node biopsy in early oral cancer11
30-day morbidity and mortality after transoral robotic surgery for human papillomavirus (HPV) associated oropharyngeal squamous cell carcinoma: A retrospective analysis of two prospective adjuvant de-11
Personalized intraoral devices in the era of high-technology head and neck radiotherapy: A resource to be explored11
Lung immune prognostic index is associated with clinical outcomes in recurrent or metastatic (R/M) nasopharyngeal carcinoma receiving immunotherapy: Results from the multicenter, single-arm, phase 2 s11
Integrative analysis of aging-related immune parameters reveals prognostic and immunotherapeutic implications in head and neck squamous cell carcinoma11
Oral cancer screening in India: a secondary analysis of disparities using national family health survey data11
Comparing BamHI-W and CE-marked assays to detect circulating Epstein-Barr Virus (EBV) DNA of nasopharyngeal cancer patients in a non-endemic area11
Letter to the editor, “The prognostic value of pretreatment 18F-FDG PET-CT parameters with peripheral blood markers in patients with de novo metastatic nasopharyngeal carcinoma.”11
Tongue cancer in non-smoking and non-alcoholic mother and daughter11
Corrigendum to “Cancer cell-derived extracellular vesicles drive pre-metastatic niche formation of lymph node via IFNGR1/JAK1/STAT1-activated-PD-L1 expression on FRCs in head and neck cancer” [Oral On11
Evaluating observer reliability and diagnostic accuracy of CT-LEFAT criteria for post-treatment head and neck lymphedema: A prospective blinded comparative analysis11
Perioperative immunotherapy for head and neck cancer: from early successes to clinical challenges in relapsed and/or metastatic disease11
Randomizing treatment is not equivalent to validating biomarker-guided intensification in high-risk nasopharyngeal carcinoma11
Authors reply to comment by Irene Lafuente-Ibáñez de Mendoza and Aguirre-Urizar JM10
Letter to the Editor: Impact of the COVID-19 pandemic on diagnosis and disease stage in HPV-positive oropharyngeal cancer: insights and future directions10
Commentary on “Predicting reactive Gastrostomy-Tube placement after head and neck free flap Reconstruction”10
Advancing precision prevention: enhancing the hypoxia–microbiota framework in oral potentially malignant disorders10
Genetic characteristics of a highly metastatic basal cell adenocarcinoma arising in buccal mucosa10
Relationship between GLUT-1 and HIF-1α: Is it a friend or foe for studying the biological behaviour of head-and-neck tumorigenesis?10
Prophylactic gastrostomy tube during chemoradiation for head and neck cancer decreases weight loss but increases rate of tube use beyond six months10
Establishing a role for the oral microbiome in infectious complications following major oral cavity cancer surgery10
Bridging the gap: From dosimetric sparing to patient-reported functional benefit in the GUARD trial10
Prophylactic feeding tube placement for squamous cell carcinoma of the head and neck10
Commentary on, “Oncologic significance of the lateral margin in buccal cancer.”10
Tumor-stroma ratio, neoangiogenesis and prognosis in laryngeal carcinoma. A pilot study on preoperative biopsies and matched surgical specimens10
Commentary on, “Prevalence of oral human papillomavirus infection among adult men and women in Taiwan (PILLOT).”10
A rare case of Merkel cell carcinoma on the craniofacial region and characterization of its aneuploid CD31− CTCs and CD31+ CTECs expressing EpCAM or Ki-6710
Comments on: The role of adjuvant radiotherapy in relation to tumor size for bone-invasive pT4aN0 oral squamous cell carcinoma − A retrospective observational matched cohort study10
Oncological outcomes of pathological extranodal extension (pENE) in oral squamous cell carcinoma (OSCC): A proposal to refine the current staging10
Comment on “Long-term health-related quality of life following segmental mandibulectomy and osseous reconstruction”10
Esophageal dysmotility in head and neck cancer survivors: a critical step forward and the path ahead!10
Predictive value of circulating tumor tissue-modified HPV DNA kinetics in induction therapy for oropharyngeal squamous cell carcinoma10
In regard to Riddhima Agarwal et al10
Comment on “Low skeletal muscle mass and not systemic inflammation is associated with complications after free forearm flap reconstruction in oral cancer patients”10
Advancing precision radiotherapy through AI/ML in appliance design and patient outcome prediction: a complement to the GUARD trial10
Lung cancer metastases to the oral cavity: Report of two cases and review of literature10
Neoadjuvant chemotherapy combined with anti-PD-1 monoclonal antibody in locally advanced resectable oral squamous cell carcinoma: efficacy evaluation and prediction10
Therapeutic strategy for advanced stages salivary carcinomas of the tongue: A multicenter REFCOR study10
The state of virtual surgical planning in maxillary Reconstruction: A systematic review10
Selective tracheostomy in oral cancer reconstruction with myomucosal flaps: Outcomes and an appraisal of published risk scores10
Donor-site morbidity in sarcopenic patients: An overlooked pathway to complications10
AI-driven histopathologic insights in HPV-positive head and neck squamous cell carcinomas10
Critical reflections on the clinical implementation of 3D-Printed oral stents for radiotherapy patients9
The association of frailty with morbidity and mortality following major mucosal head and neck surgery9
Systematic classification of confocal laser endomicroscopy for the diagnosis of oral cavity carcinoma9
Malignant odontogenic tumors. A report of a series of 30 cases and review of the literature9
Reliability of gene-expression profiling from tumor biopsy for refining neoadjuvant strategies in patients with head and neck squamous cell carcinoma9
Comments on, “Interdisciplinary approaches to diagnosing oral cavity skin cancers: The Dentist’s involvement in detecting dermatological conditions”9
Comment on “Robotic parotidectomy via retroauricular incision: A safe and feasible approach for benign parotid tumors”9
Exuberant clear cell odontogenic carcinoma of the mandible harboring EWSR1 rearrangement: Report of a rare case and a literature review9
Metastasis to the ciliary body and iris from a parotid carcinoma9
High expression of H2AX/γ-H2AX is associated with distinct biological pathway alterations and shorter survival in oropharyngeal squamous cell carcinoma9
Ensemble learning-based radiomics model for predicting radiation-induced temporal lobe injury in nasopharyngeal carcinoma9
Predicting outcomes in head and neck surgery with modified frailty index and surgical apgar scores9
Delineating atypia and dysplasia – Addressing the grey zone9
A rare case of a dormant malignancy in long-standing tongue ulceration9
Comment on “Neighborhood socioeconomic status and race are associated with incidence disparities in oral cavity cancers”9
Editorial Board/Aims & Scope9
P23 Dual targeting of PARP and Wee1 for effective radiosensitization of HNSCC9
In reply to “Risk of cardiovascular disease among head and neck cancer survivors: A population-based matched cohort study”9
Correlation between radiological, macroscopic and microscopic depth of invasion in oral squamous cell carcinoma: A prospective study using contrast-enhanced computed tomography9
Postoperative complications of neck dissection for head and neck squamous cell carcinoma: a systematic review and meta-analysis9
Prognostic factors in surgically treated malignant salivary gland tumors9
Radiotherapy-induced bilateral hypoglossal nerve palsy with xerostomia and xerophthalmia9
Individualized radiology screening for newly diagnosed nasopharyngeal carcinoma9
P05 Study of viral Biomarkers and MicroRNAs in HPV-associated Oropharyngeal cancer and cancer of unknown primary9
P01 Survival outcomes related to treatment modalities in patients with oropharyngeal squamous cell carcinoma9
Comment on “Elective neck dissection: Desideratum or overkill?”9
Sentinel node biopsy in node negative early oral cancers: Solution to the conundrum!8
Selected laryngeal squamous cell carcinomas with laryngeal mobility impairment are suitable for curative larynx-preservation treatment8
Application of patient derived xenograft model in personalized drug screening for chondrosarcoma of head and neck: A preclinical study8
0.43677186965942